Transcript Highlights:

• TODAY 280 MILLION AMERICANS ROUGHLY RECEIVE THAT PRESCRIPTION DRUG BENEFIT FOR A PBM SO WE WILL SHARE
• THE PBM IS NOW ONLY INSURANCE COMPANY AND THEY GOT A HECK OF A DEAL.
• PBM IS IN THIS BILL WILL NO LONGER BE ALLOWED TO CONTROL WHETHER THEIR PHARMACY CAN DECLINE TO FILL A
• HOWEVER ONE OF THE SPEAKERS SPOKE ABOUT THE ISSUES WITH THE MANUFACTURERS AND TO THE PBM RELATIONSHIP
• AND PBM GAME.

Transcript Highlights:

• I everything that goes on between PBMs.
• > um stuff about PBMs, um stuff about PBMs, um if<01:57:05.000> I<01:57:05.120> had<
• This does of PBM legislation out there.
• Steering to the PBM of PBM.
• related to PBM. Okay. related to PBM. Okay.

Keywords: 1189, house, all

Transcript Highlights:

• is a very big issue in the Pacific Northwest. for farmers and consumers, and the litigation against PBMs
• In the house, I was able to co-lead a bipartisan effort to to rein in PBMs and want to continue to do
• And then I know you've got a question from one of my colleagues on PBMs.
• actions by PBMs.
• I've been looking at PBMs since I was in law school, writing about them.

Keywords: Senate Committee, Commerce, Science, Technology, Quantum Computing, Artificial Intelligence, FTC, Consumer Protection, Innovation, Emerging Technologies

Summary: The meeting of the Senate Committee on Commerce, Science, and Transportation featured significant discussions regarding technological advancements and their implications for the future. Notably, nominations were made for key positions in the White House's Office of Science and Technology Policy and the Federal Trade Commission. Committee members expressed the importance of leading in emerging technologies like artificial intelligence and quantum computing, emphasizing that the pace of innovation is crucial for maintaining the United States' global position as a leader in technology. The discussions also highlighted the role of the FTC in protecting consumers from deceptive business practices and ensuring fair competition in the marketplace. Attendees underscored the urgency of advancing research and development in areas such as quantum computing, as evidenced by a demonstration of a new quantum chip anticipated to redefine computing capabilities across industries. Various members engaged in vibrant exchanges, showing support for initiatives aimed at bolstering innovation through public and private collaboration. Overall, the meeting set a strong agenda for pursuing future science and technology policies that ensure the U.S. remains at the forefront of global advancements.

Transcript Highlights:

• largest three PBMs in the country, they are one and the same.
• A Medicaid PBM is an affiliate of a Medicaid pharmacy, where the PBM can set the rate of reimbursement
• I want to make sure we heard correctly that we can have a situation where a PBM owns the PBM owns the
• PBM owns the PBM and the pharmacy.
• The PBM data reported to HHSC shows the full $148.50.

Keywords: 1185, senate, all

Transcript Highlights:

• It's bigger than the Medicaid program, and a lot of for-profit PBMs and chain pharmacies have gotten
• It's bigger than the Medicaid program, and a lot of for-profit PBMs and chain pharmacies have gotten
• It's bigger than the Medicaid program, and a lot of for-profit PBMs and chain pharmacies have gotten
• That's what shows up: 84% of non-PBM-owned pharmacies are not affiliated with PBMs or chains.
• <01:21:44.320> owned what shows up 84% of non PBM owned what shows up 84% of non PBM owned

Keywords: 00:00:00 Call to Order/Roll Call 00:01:19 Discussion of 25RS HB 785 00:30:25 Roll Call Vote on 25RS HB 785 00:32:15 Discussion of 25RS HB 61 00:36:42 Roll Call Vote on 25RS HB 61 00:38:07 Discussion of 25RS HB 788 00:51:01 Discussion of 25RS SB 14 01:11:09 Discussion of 25RS HB 685 01:44:57 Adjournment, 958, all

Summary: The House Standing Committee on Health Services met with a quorum and took up House Bill 785, as amended by a committee substitute that combined language from HB 785 and HB 787. The bill was described as addressing Medicaid managed care organization (MCO) audits, provider contract notice and amendment procedures, mental health parity compliance, and related transparency requirements. Supporters said the measure would tighten notice to providers, limit repeated contract amendments and rate reductions, require more standardized audit procedures, and add reporting on Medicaid claims, appeals, and grievances. It also includes a provision requiring coverage of at least two evaluation-and-management billable services per physician per recipient per date of service, and a section addressing narcotic/opioid treatment program licensing and reimbursement language. Testimony in support came from Representative Kim Moore, John Inman of BrightView Health, Michelle Sandborne of the Children’s Alliance, and Kelly Cormic of RYSE. They argued that MCOs often use audits and recoupments in ways that are burdensome, opaque, and financially damaging to providers, especially smaller and rural ones. They cited examples of multiple audit requests in short timeframes, large record requests with short deadlines, delayed or absent feedback, and recoupments taken before appeals are resolved. They also said parity laws are not being consistently enforced and that the bill would give the Department of Insurance authority to suspend or revoke an MCO certificate of authority for willful or repeated parity violations. Committee members generally expressed support for provider protections and transparency, while asking for clarification on the narcotic treatment and E/M billing provisions. Tom Stevens of the Kentucky Association of Health Plans testified in opposition, saying the bill is complex to implement and should be handled through the broader Medicaid oversight work of House Bill 9, the MOAB. He said the issues raised were better suited for that bipartisan stakeholder process and noted the committee substitute had not yet been fully reviewed by his group. After discussion, the committee adopted the committee substitute and then moved to a vote on the bill; the roll call began, with several members recorded as voting yes, but the transcript cuts off before the final vote result is shown.

Transcript Highlights:

• your in-house PBM or others, but...
• Does your PBM contract that you have clearly state that? Yes.
• PBM probably has a lot of places in Texas covered, I would imagine.
• I asked about PBMs, right? Y'all have, you don't have in-house PBMs being a non-profit, correct?
• We have contracts with a PBM, an independent PBM. Who pays the pharmacies on our behalf?

Bills: HB149, HB252, HB643, HB1442, HB1500, HB1672, HB1851, HB1893, HB2028, HB2768, HB2818, HB149, HB252

Keywords: artificial intelligence, regulation, biometric data, ethical AI, consumer protection, AI governance, employment compensation, state agencies, salary payments, general appropriations, government efficiency, public works, contractors, payment bonds, government contracts, construction law, transparency, open meetings, government accountability, public access

Transcript Highlights:

• Last Congress, we passed the PBM Reform Act, reforming malaligned incentives for PBMs and ensuring that
• to lower the price of prescription drugs by taking on the greed of the pharmacy benefit managers, PBMs
• I think it's PBMs; I think it's the greed of the drug companies.

Transcript Highlights:

• He explained that they examined prescription drug pricing, where PBMs negotiate rebates after the fact
• pbms negotiate rebates<00:16:37.880> um<00:16:38.319> and<00:16:38.600> and<00:
• we at the pdab don't have access to pbms we at the pdab don't have access to those<00:16:55.279>
• It is subsidized by the federal government, but they also use PBMs.
• It is subsidized by the federal government, but they also use PBMs.

Keywords: 928, house, all

Summary: The working session focused on the New Hampshire Prescription Drug Affordability Board’s budget request and its recent work. Early discussion centered on a technical question about a statutory dedicated fund for donations: members asked why the budget did not show a line item for accepting donations, and DHHS CFO Nathan White explained that the statute already authorizes the fund, but because no revenue has been received yet, it does not appear in the budget. He said any future donations would go through the normal process under RSA 14:30-a, with fiscal committee and Governor and Council approval and a memo to the Department of Revenue Administration. The chair clarified that the account was not a prerequisite to soliciting donations, and White said the fund would supplement, not replace, General Fund support. Kirk Williamson, the board’s executive director, then presented the board’s mission and budget. He said the governor’s budget provides about $256,500 in the first year and slightly more in the second, all General Funds, and that the board had distributed a technical amendment to continue the executive director position. He described the board’s role as analyzing prescription drug costs, identifying savings opportunities, monitoring market trends, promoting transparency, and making recommendations to the legislature and public payers. He also emphasized that the board operates publicly, with live-streamed meetings and a stakeholder advisory council that includes unions, state agencies, Medicaid, corrections, higher education, and other stakeholders. A major topic was the board’s estimate of $6 million in potential savings, based on Medicare’s newly negotiated prices for 10 drugs. Williamson explained that the board used those federal negotiated prices as a benchmark to estimate what New Hampshire public payers might be missing by not having similar leverage, and said the board is trying to build evidence for future recommendations rather than directly setting prices. Members asked how those potential savings could become actual savings, and Williamson said the board is sharing findings through its advisory council and feedback loops, though it has not yet sent a formal recommendation letter to specific purchasers. He also discussed the difference between pharmacy-benefit spending, which relies heavily on PBM-negotiated rebates, and medical-benefit spending, which is administered differently and is being added to the board’s next report. Williamson highlighted other work, including a model on Humira and a pending legislative effort to improve biosimilar competition, plus a proposed state-backed pharmacy savings card that would be no cost to the state and could save users about $240 per prescription based on Connecticut’s experience. No votes were taken during the session.

Transcript Highlights:

• The most recent 2021 dispensing survey states that an average cost of $11.55, while PBMs and managed
• managers or pbms in this case by pbms managers or pbms in this case by pbms contracted<00:48:40.599
• Once a local pharmacy like us closes, we won't be back until PBM reform is achieved.
• more, to tell the PBMs they must pass this money along to the pharmacy.
• more and tell the PBMs to pass the money along to pharmacies.

Keywords: 1183, house

Transcript Highlights:

• The PBM language starts on line 27 of that same page, page 5, and that continues on until page 6.
• the covered entities, beginning January 1, 2026, and then to the manufacturers, health insurers, and PBMs
• was done originally because there were a lot of questions about some of those other areas with the PBMs
• any specific concerns, and maybe somebody here can address them if I'm missing it, but some of the PBM
• I don't know what the status is of that PBM bill in the Senate, but I don't know if any of this language

Keywords: 908, all

Summary: The committee met with a quorum and took up the final bill on its agenda, Senate Bill 2370, which had been converted into a 340B drug transparency measure tied to insulin and broader prescription drug pricing issues. Representative Hendrix outlined the latest bill draft, explaining that it would require reporting by covered entities, contract pharmacies, federally qualified health centers, drug manufacturers, pharmacy benefit managers, and health insurers, with confidentiality protections, civil penalties, and staggered effective dates. He also noted unresolved questions about the scope of required reporting, possible overlap with federal reporting, and whether the Insurance Department would need a consultant to analyze the data. Representative Dobervich then proposed an alternative amendment that would replace the bill language with a Legislative Management study on 340B transparency reporting during the 2025-26 interim. Her proposal would remove the detailed reporting mandates and instead direct a study of what information should be collected, how it should be used, who should receive it, staffing or contracted support needs, and stakeholder input from hospitals, pharmacies, FQHCs, rural health, state agencies, insurers, and manufacturers. Members discussed germaneness, the late-stage nature of the changes, and whether the issue had been adequately heard, while the Insurance Department testified that it had not previously studied 340B-specific data but supported transparency and could see value in either a study or reporting approach. The committee first adopted the Hendrix amendment by a vote of 8-5, then voted on a do not pass motion on the amended bill, which passed 7-6. Representative Frelich was selected to carry the bill. The chair then adjourned the committee for the last time and reminded members about the committee dinner.

Transcript Highlights:

• So they're processing through the PBM, and the PBM is saying charge retail, right?
• PBM and the PBM processing through the PBM and the PBM is<03:02:42.600> saying<03:02:42.920><
• pbms pbms okay<03:03:27.560> any<03:03:27.760> other okay any other okay any other questions
• I can't speak to what the PBMs are doing.
• I can't speak to what the PBMs are doing.

Keywords: 1191, senate, all

Transcript Highlights:

• PBMs, and we have the highest drug cost in the world.
• PBMs, drug companies, and wholesale are all making tons of money.
• versus what PBMs negotiate with others.
• versus what PBMs negotiate with others.
• versus what PBMs negotiate with others.

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a lengthy public hearing with testimony on a wide range of health insurance and access-to-care bills. Early testimony focused on prescription drug pricing and pharmacy reimbursement, with supporters of H. 1326 arguing that pharmacy benefit managers and MassHealth managed care arrangements reimburse independent pharmacies too little, contributing to pharmacy closures and “pharmacy deserts.” The committee also heard repeated support for H. 1151/S. 742 on cognitive rehabilitation for acquired brain injury, H. 1288/S. 716 on telehealth parity for nutrition counseling, H. 1309/S. 761 on full-spectrum pregnancy care without cost-sharing, H. 1312 on insurance coverage for doula services, H. 309 on prompt access to health care by removing deductibles for certain services, H. 809/H. 1227 on biomarker testing, H. 1162/S. 810 on reducing inequities in access to medical procedures by limiting insurer cuts tied to Modifier 25, and S. 726 on insurance coverage for mobile integrated health. Testifiers included legislators, physicians, pharmacists, dietitians, emergency and rehabilitation clinicians, and patients and family members. Supporters of the brain injury bill said cognitive rehabilitation is medically necessary, improves long-term outcomes, and can reduce institutional care and public costs; they noted the bill has been heard repeatedly and has support from the Brain Injury Commission and prior favorable committee action. Supporters of the pregnancy care and doula bills described out-of-pocket costs as a barrier to maternal health and shared personal stories of high bills and unmet support needs. Biomarker testing advocates and cancer patients said coverage gaps deny patients access to precision treatment, can lead to avoidable suffering, and should be standardized across insurers; several speakers said insurers often deny claims despite clinical benefit. Dermatology witnesses said insurers’ use of Modifier 25 cuts reimbursement for same-day evaluation and procedure visits, forcing separate appointments and increasing patient burden. Mobile integrated health supporters described home-based care as a way to reduce emergency department use and hospital readmissions, especially for patients with transportation or mobility barriers. No votes or formal committee actions were taken during the hearing itself.

Transcript Highlights:

• As you know, we've had many issues on the PBMs.
• ability for the PBM to deny them payment for something that they have done.
• ability for the PBM to deny them payment for something that they have done.
• ability for the PBM to deny them payment for something that they have done.
• We have approximately 70 PBMs that operate in today's marketplace.

Bills: S0006, S0026, S0206, S0532, S0576, S1012, S1110, S1178, S1192, S1758, S1760, S7046, S7048

Keywords: child welfare, negligence, settlement, injury compensation, Department of Children and Families, motorcycle accident, compensation, Department of Transportation, legal claim, autism, autism spectrum disorder, ASD, special education, exceptional student education, ESE, teacher preparation, educator certification, micro-credential, loan forgiveness, student loan repayment

Summary: The Appropriations Committee met and considered a large agenda of bills, reporting several measures favorably. Early action included SB 6, a settled claim bill involving the Department of Children and Families and the estate of Leila Estrada and Sapphire Williams, which was approved for $3.8 million. The committee also passed a cybersecurity internships bill creating a Department of Commerce program with Cyber Florida, and SB 532, which lets clerks of court retain the full amount of certain excess revenue and clarifies foreclosure-sale procedures. Veterans housing measures, CS for CS for SB 1602 and SB 1604, were approved to create a pilot program and a related trust fund for vacancy relief and risk mitigation for veteran housing. The committee also favorably reported SB 1110 on Medicaid and insurance coverage for orthotics and prosthetics, with emotional testimony from a student and family describing the high cost and importance of activity-specific prosthetics. Members also approved CS for CS for SB 1012 after adopting an amendment that removed inmate emergency and specialty medical service compensation provisions while retaining changes to the contractor-operated institutions inmate welfare trust fund. Another bill, CS for CS for SB 1614, was narrowed by a delete-all amendment to focus on limiting the use of excess fees for new building construction by local governments. All of these measures were reported favorably after brief debate, with some support testimony submitted in writing or waived. The most extensive discussion centered on CS for CS for SB 17, a major Medicaid and public assistance overhaul. The bill would create a Joint Legislative Committee on Medicaid Oversight, allow the Legislature to retain its own actuary, tighten Medicaid program oversight, update encounter-data reporting, set performance standards for managed care plans, revise pharmacy benefit manager rules, and require DCF to implement SNAP fraud-reduction and payment-accuracy reforms, including photo IDs on EBT cards and updated work requirements. It also would direct agencies to seek federal waivers for Medicaid work requirements for able-bodied adults and expanded behavioral health services. After lengthy questioning and testimony, the committee adopted amendments adding a transitional medical benefits glide path for people who gain employment and later lose Medicaid eligibility, and exempting hospice patients with six months or less to live. Supporters argued the bill would improve accountability, reduce fraud, and save money, while opponents warned it would create administrative burdens, increase paperwork, and cause eligible people to lose coverage or food assistance. The committee ultimately reported the bill favorably as amended.

Transcript Highlights:

• It's because they're not affordable due to the way the PBMs are processing them.
• prescription drug coverage is made to pay more than someone without insurance simply because of the PBM
• reason a patient should be incentivized to pay more for prescription drugs, but that's exactly how the PBMs
• This bill is a step towards restoring trust, reining in harmful PBM practices, and putting patients first

Bills: HB854, HB 1052, HB1642, HB2076, HB3042, HB3695, HB3787, HB4062, HB4092, SB213, SB493, SB896, HB5519, HB4635

Keywords: insurance, replacement cost, homeowner's policy, renter's policy, condominium insurance, property damage, claims process, telemedicine, teledentistry, telehealth, health benefit plan, insurance coverage, out-of-state services, anxiety, pain management, contraceptive devices, women's health, medical procedures, healthcare, laboratory

Bills: HB854, HB 1052, HB1642, HB2076, HB3042, HB3695, HB3787, HB4062, HB4092, SB213, SB493, SB896, HB5519, HB4635

Keywords: insurance, replacement cost, homeowner's policy, renter's policy, condominium insurance, property damage, claims process, telemedicine, teledentistry, telehealth, health benefit plan, insurance coverage, out-of-state services, anxiety, pain management, contraceptive devices, women's health, medical procedures, healthcare, laboratory

Transcript Highlights:

• When the PBM... ...adjudicated the claim, it indicated the patient should be charged $89.18.
• That is exactly how... ...the PBM to design our prescription drug system.
• Cash price versus the other price, the PBM markup for processing and market share.
• Price that the PBM providers could kind of pull you out of their network. Do we know that?
• As a contract with a PBM, I would assume. I don't know if it's vertical or not.

Bills: SB95, SB268, SB493, SB619, SB660, SB922, SB984, SB1098, SB1188, SB1307, SB1332, SB1822

Keywords: immunization, written informed consent, civil liability, health care provider, vaccine compensation, administrative penalty, health care, licensing, complaint procedure, disciplinary action, law enforcement, pharmacy benefit manager, PBM, gag clause, prescription drug pricing, out-of-pocket cost, cash price, pharmacist, pharmacy, prescription drug benefit

Transcript Highlights:

• , so we know which PBMs are operating in the state.
• so we know which registration of pbms so we know which pbms<01:32:39.440> are<01:32:39.560>
• since we don't believe definition of PBM since we don't believe that<01:36:16.320> the<01:36:
• and achieving low centered around pbms and achieving low of<01:36:20.560> passor<01:36:21.119
• I've got some statistics from some independent reporting agencies that have looked into PBM reform in

Keywords: 910, house, all

Summary: The committee first took up SB 1494 on hearing aids. Testimony was generally supportive of expanding hearing-aid coverage, with the Insurance Division raising concern about possible federal defrayment issues, SHPDA supporting the goal of hearing augmentation, DCAB strongly supporting the bill as an important access issue, and health plans and insurers asking for amendments. Kaiser Permanente and the Hawaii Association of Health Plans requested changes to add a medical-necessity standard and clarify annual notice language, while HMSA suggested the proposal should be studied by the auditor. The chair noted concerns about federal preemption and the lack of an audit, and deferred the bill in favor of a related resolution calling for a study. The committee then heard SB 1448, an emergency appropriation for the Hawaii State Hospital. DAGS and the Department of Health supported the measure, with the hospital administrator saying the funding would improve the environment of care, support cleaning, and allow a third-party review of the building. Committee members questioned the size of the request and the status of litigation against the design-builder. Administration witnesses said they were pursuing a comprehensive study involving destructive testing, had made a demand on the design-builder to fund the study, and were using different processes than before. They also said the roof work would be handled through a separate CIP request. No final action was taken in the portion provided. The committee next heard SB 1432, relating to the future responsibilities of the Department of Health and land issues at Kalaupapa after the last patient dies. DOH supported the bill in part but said its long-term role would be limited mainly to environmental cleanup, with operations expected to continue under the National Park Service and land-use decisions left to DHHL and beneficiary consultation. DHHL asked that the measure reflect that any land-use or zoning changes on homeland lands require commission approval and beneficiary consultation. Testifiers from Kalaupapa and Maui County, including Degra Vanderbilt-Papa and Council Member Keani Rollins-Fernandez, supported deferring the bill, saying there had been no meaningful community discussion about provisions affecting Kalaupapa’s future management and possible transfer of responsibilities to Maui County. The committee also read into the record written testimony from Gloria Marks emphasizing that Kalaupapa stakeholders must be included in future discussions. Finally, the committee heard SB 955 on fitness-to-proceed examinations. The Judiciary and the Public Defender’s Office both supported raising pay and standardizing expectations for private examiners, but opposed reducing felony fitness evaluations from three examiners to one and opposed expanding use of expedited reports. They argued that a single examiner would reduce reliability, create a more adversarial process, and likely increase costs and contested hearings, while expedited reports do not contain enough information for a proper fitness determination. The Department of Health also supported the bill’s intent but asked to preserve a three-examiner framework and said the goal was to reduce the number of people sent to the State Hospital, where admissions have reportedly risen about 20% year over year since Act 26. The bill remained under discussion in the excerpt, with no final vote shown.

Transcript Highlights:

• Members, we're taking a different look at how the state regulates PBMs.
• Number one, the PBMs can only administer a flat fee.
• That's what PBMs do.
• Every legislation we file with insurance, PBMs, 340B is constantly a lawsuit.
• Every legislation we file with insurance, PBMs, 340B is constantly a lawsuit.

Bills: HR115, HR116, HR117, HR118, HR112, HR113, HR114, HCR51, HCR52, SCR18, SCR20, SB14, SB76, SB118, SB142, SB156, SB170, SB197, SB234, SB258, SB287, SB288, SB313, SB315, SB393, SB396, SB426, SB427, HCR7, HB76, HB84, HB132, HB181, HB210, HB250, HB265, HB275, HB291, HB322, HB342, HB457, HB475, HB477, HB486, HB616, HB635, HB639, HB690, HB740, HB757, HB761, HB766, HB774, HB808, HB855, HB866, HB872, HB883, HB886, HB903, HB949, HB962, HB996, HB1003, HB1036, HB1054, HB1071, HB1076, HB1078, HB1113, HB1132, HB1146, HB1232, HB1233, HR15, HR20, HCR14, HCR6, HCR19, HCR10, HR74, HCR26, HCR35, HB98, HB108, HB131, HB151, HB161, HB288, HB294, HB305, HB310, HB320, HB336, HB380, HB392, HB403, HB420, HB459, HB476, HB540, HB615, HB631, HB637, HB648, HB665, HB682, HB789, HB813, HB815, HB835, HB870, HB905, HB915, HB933, HB938, HB987, HB1040, HB51, HB82, HB143, HB145, HB160, HB180, HB192, HB393, HB430, HB445, HB506, HB515, HB521, HB565, HB590, HB614, HB638, HB670, HB672, HB685, HB692, HB752, HB773, HB781, HB799, HB860, HB874, HB887, HB917, HB937, HB956, HB965, HB972, HB977, HB982, HB1006, HB1010, HB1044, HB1072, HB1088, HB1179, HB1200, HB81, HB400, HB154, HB410, HB463, HB827, HB868, HB952, HB953, HB140, HB750, HB911, HB52, HB961, HB399, HB401, HB901, HB9, HB58, HB193, HB284, HB570, HB577, HB582, HB605, HB733

Keywords: Kappa Alpha Psi, fraternity, Louisiana, commemoration, community engagement, recognition, state championship, basketball, sports achievement, school commendation, commendation, athletics, team sports, youth, community recognition, water utility, tax credit, excessive rates, residential service, subcommittee

Transcript Highlights:

• We're actually, timing-wise, in the middle of getting ready to put our PBM contract out to bid.
• And so hopefully we'll get some favorable terms this year on our PBM contract.
• I have one other question with regard to, you said you're going to renew your PBM contract?
• We are in the midst of issuing a PBM RFP into this month.
• Do you happen to know if Medicaid's pharmacy program has a PBM or if they do it all themselves?

Keywords: 959, house, all

Transcript Highlights:

• Control of drug pricing by PBMs<00:33:24.720> have<00:33:24.880> driven<00:33:25.120>
• > out<00:33:25.559> independentarmacies PBMs have driven out independentarmacies PBMs have
• Um, talking to insurance, your PBMs, uh, trying to get appointments, all of those pieces don't feel like
• Um, talking to insurance, your PBMs, uh, trying to get appointments, all of those pieces don't feel like
• Um, talking to insurance, your PBMs, uh, trying to get appointments, all of those pieces don't feel like

Keywords: 1187, senate, all